any investor wanting to learn who is a decoy (and i'll

New Post Public Reply Private Reply Replies (1) Message Board
4kids 4kids #3694
237
any investor wanting to learn who is a decoy (and i'll follow this post with some RT notes from today's activated *decoys*) .. has to learn to note who *shows* vs who *reports* via the MM Monthly

http://otce.finra.org/MonthlyShareVolume

i tend to focus on the daily signals (and where placed on l2) provided by the PRIMARY/SECONDARY and TERTIARY MMs' reporting to Finra

Below are the 3 MMs' who *factually* reported activity to Finra since this time last year .. May 2017 to April 2018 .. as well as the number of MMs' *participating per month* and *volume by month*

you can clearly see who the PRIMARY/SECONDARY and TERTIARY MMs' are re: IPIX

this is important in understanding the role decoys' play in regards to what l2 *shows* on any given day but mostly as is always the case with an *imo* OTC SURVIVOR .. what is revealed over weeks/months and in some cases .. years

that is also why i can note which MM .. is usually acting as a decoy on l2 ..

note exactly the volume done per month (which is why you can see these same
Marker Manipulators lying in regards to *avg* daily volume .. as has been noted
via *legal* as being in the 500k range) .. that remains factually false .. it's closer
to 200k on any given week recently .. but what is really worth noting is who doesn't deviate from the first 3 spots .. each and every month .. you can also observe the fact of *decoys* willing to play the UPSIDE DOWN GAME .. with MMs' (back in 2015 .. running 25 to 29) ..MMs now *reporting* between 9 to 11 for IPIX (13 for May 17 .. CTIX) .. are *actually decreasing*

as i've always noted *volume* tells the tale of where in the cycle NR and CEs *are*

volume will relo UP the 10 and 90 day avgs .. but will a price (daily reg sho % marked) have to paid?

the other fact that can't be ignored to suit is the %s' posted by only 3 MMs every month .. since May 2017 .. 69% to 87% reveals why the round robining rotation of *volume* reported is well in hand by just 3 MMs CON tinues to ramp upwards

make no mistake an educated retail investor is a colluding entity's worst NITE mare (pun intended)

APRIL 2018 .. IPIX Volume ~ 4,473,436
10 MMs' reporting ..
( ETRF/NITE @ 27% .. CDEL @ 20% ) .. total = 75.16% of *volume*
( ARCA .. OTCX .. CSTI @ 9% .. 8% and 4% )
( CANT .. LAFC .. PUMA .. STXG all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 4,473,436 4,078,577 17,073,621 ETRF G1 EXECUTION SVCsETRF, LLC 1,240,454 1 27.73%
IPIX Innovation Pharma 4,473,436 4,078,577 17,073,621 NITE VIRTU AMERICAS LLC 1,216,167 2 27.19%
IPIX Innovation Pharma 4,473,436 4,078,577 17,073,621 CDEL CITADEL SECURITIES LLC 905,353 3 20.24%



MARCH 2018 .. IPIX Volume ~ 4,078,577
11 MMs' reporting ..
( ETRF/CDEL/NITE @ 30% ..24% .. 22% ) .. total = 77.55% of *volume*
( ARCA & CSTI @ 10% and 5% )
( OTCX .. LAFC .. CANT .. VERT .. MAXM .. PUMA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 4,078,577 3,388,387 12,600,185 ETRF G1 EXECUTION SVCs, LLC 1,247,854 1 30.6%
IPIX Innovation Pharma 4,078,577 3,388,387 12,600,185 CDEL CITADEL SECURITIES LLC 1,004,220 2 24.62%
IPIX Innovation Pharma 4,078,577 3,388,387 12,600,185 NITE VIRTU AMERICAS LLC 910,681 3 22.33%


FEBRUARY 2018 .. IPIX Volume ~ 3,388,387
10 MMs' reporting ..
( ETRF @ 34% .. NITE & CDEL @ 24% ) .. total = 83.04% of *volume*
( ARCA .. CSTI .. LAFC @ 6% .. 4% and 3% )
( CANT .. VERT .. PUMA .. VNDM all sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 3,388,387 5,133,221 8,521,608 ETRF G1 EXECUTION SVCs, LLC 1,152,418 1 34.01%
IPIX Innovation Pharma 3,388,387 5,133,221 8,521,608 NITE VIRTU AMERICAS LLC 838,168 2 24.74%
IPIX Innovation Pharma 3,388,387 5,133,221 8,521,608 CDEL CITADEL SECURITIES LLC 822,921 3 24.29%



JANUARY 2018 .. IPIX Volume ~ 5,133,221
9 MMs' reporting ..
( NITE @ 33% .. ETRF @ 25% .. CDEL @ 23% ) .. total = 82.27% of *volume*
( ARCA .. CSTI .. LAFC @ 6% .. 5% .. 2% )
( CANT .. PUMA .. MAXM .. all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume


 
IPIX Innovation Pharma 5,133,221 8,121,069 5,133,221 NITE VIRTU AMERICAS LLC 1,721,407 1 33.53%
IPIX Innovation Pharma 5,133,221 8,121,069 5,133,221 ETRF G1 EXECUTION SVCs, LLC 1,296,054 2 25.25%
IPIX Innovation Pharma 5,133,221 8,121,069 5,133,221 CDEL CITADEL SECURITIES LLC 1,206,032 3 23.49%



DECEMBER 2017 .. IPIX Volume ~ 8,121,069
11 MMs' reporting ..
( NITE @ 35% .. CDEL @ 23% .. ETRF @ 18% ) .. total = 76.89% of *volume*
( ARCA .. CSTI .. LAFC .. CANT @ 8% .. 6% .. 3% .. 2% )
( VERT .. MAXM .. INTL .. PUMA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 8,121,069 4,031,082 62,497,265 NITE VIRTU AMERICAS LLC 2,886,476 1 35.54%
IPIX Innovation Pharma 8,121,069 4,031,082 62,497,265 CDEL CITADEL SECURITIES LLC 1,896,344 2 23.35%
IPIX Innovation Pharma 8,121,069 4,031,082 62,497,265 ETRF G1 EXECUTION SVCs, LLC 1,461,977 3 18%



NOVEMBER 2017 .. IPIX Volume ~ 4,031,082
11 MMs' reporting ..
( NITE @ 31% .. ETRF @ 25% .. CDEL @ 22% ) = total of 79.71% of *volume*
( VERT/CANT/ARCA/LAFC/CSTI .. @ 6% .. 4% .. 3% .. 3% .. 2% )
( PUMA .. MAXM .. AEXG all sub 1% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 4,031,082 3,856,915 54,376,196 NITE VIRTU AMERICAS LLC 1,283,920 1 31.85%
IPIX Innovation Pharma 4,031,082 3,856,915 54,376,196 ETRF G1 EXECUTION SVCs, LLC 1,032,596 2 25.62%
IPIX Innovation Pharma 4,031,082 3,856,915 54,376,196 CDEL CITADEL SECURITIES LLC 896,653 3 22.24%



OCTOBER 2017 .. IPIX Volume ~ 3,856,915
11 MMs' reporting ..
( NITE .. ETRF .. CDEL @ 33% .. 27% .. 25% ) .. total = 87.51% of *volume*
( LAFC .. CSTI .. VERT @ 3% .. 3% .. 2% )
( CANT .. STXG .. VNDM .. PUMA .. MAXM all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 3,856,915 2,395,379 50,345,114 NITE VIRTU AMERICAS LLC 1,304,156 1 33.81%
IPIX Innovation Pharma 3,856,915 2,395,379 50,345,114 ETRF G1 EXECUTION SVCs, LLC 1,068,898 2 27.71%
IPIX Innovation Pharma 3,856,915 2,395,379 50,345,114 CDEL CITADEL SECURITIES LLC 1,002,365 3 25.99%



SEPTEMBER 2017 .. IPIX Volume ~ 2,395,379
9 MMs' reporting ..
( NITE .. ETRF .. CDEL @ 33% .. 25% .. 21% ) .. total = 80.32% of *volume*
( VERT .. CSTI .. CANT @ 12% .. 3% .. 2% )
( LAFC .. ARCA .. PUMA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 2,395,379 3,276,355 46,488,199 NITE VIRTU AMERICAS LLC 807,293 1 33.7%
IPIX Innovation Pharma 2,395,379 3,276,355 46,488,199 ETRF G1 EXECUTION SVCs, LLC 603,325 2 25.19%
IPIX Innovation Pharma 2,395,379 3,276,355 46,488,199 CDEL CITADEL SECURITIES LLC 513,444 3 21.43%



AUGUST 2017 .. IPIX Volume ~ 3,276,355
9 MMs' reporting ..
( NITE .. CDEL .. ETRF @ 33% .. 29% .. 21% ) .. total = 84.14% of *volume*
( VERT @ 9% )
( LAFC .. CANT .. CSTI all @ 2% )
( PUMA .. VNDM @ sub 1% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 3,276,355 4,896,207 44,092,820 NITE VIRTU AMERICAS LLC 1,099,604 1 33.56%
IPIX Innovation Pharma 3,276,355 4,896,207 44,092,820 CDEL CITADEL SECURITIES LLC 959,917 2 29.3%
IPIX Innovation Pharma 3,276,355 4,896,207 44,092,820 ETRF G1 EXECUTION SVCs, LLC 697,321 3 21.28%



JULY 2017 .. IPIX Volume ~ 4,896,207
10 MMs' reporting ..
( CDEL .. NITE .. ETRF @ 35% .. 31% .. 12% ) .. total = 80.42% of *volume*
( CSTI/CANT @ 6% per .. CANT .. LAFC @ 4% .. 2% )
( ARCA PUMA MAXM all @ sub 1% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 4,896,207 6,863,055 40,816,465 CDEL CITADEL SECURITIES LLC 1,752,747 1 35.8%
IPIX Innovation Pharma 4,896,207 6,863,055 40,816,465 NITE VIRTU AMERICAS LLC 1,559,023 2 31.84%
IPIX Innovation Pharma 4,896,207 6,863,055 40,816,465 ETRF G1 EXECUTION SVCs, LLC 625,666 3 12.78%



JUNE 2017 (note now IPIX) .. IPIX Volume ~ 6,863,055
11 MMs' reporting ..
( CDEL .. NITE .. ETRF @ 37% .. 30% .. 12% ) .. total = 80.50% of *volume*
( CSTI .. CANT .. LAFC .. @ 8% .. 4% .. 3% )
( ARCA .. MAXM .. PUMA .. VNDM .. MICA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 6,863,055 5,182,012 35,920,258 CDEL CITADEL SECURITIES LLC 2,569,233 1 37.44%
IPIX Innovation Pharma 6,863,055 5,182,012 35,920,258 NITE KCG AMERICAS LLC 2,078,242 2 30.28%
IPIX Innovation Pharma 6,863,055 5,182,012 35,920,258 ETRF G1 EXECUTION SVCs, LLC 877,231 3 12.78%



MAY 2017 .. CTIX ( 52 week low *reset* to 63c on 5.10.17 ) Volume ~ 5,182,012
13 MMs' reporting ..
( CDEL .. NITE .. ETRF @ 43% .. 14% .. 11% ) .. total = 69.69% of *volume*
( ARCA & CSTI @ 10% .. CANT @ 5% )
( ARXS .. PUMA .. LAFC .. STXG .. VNDM .. MAXM .. FTBR all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
CTIX Cellceutix Corp 5,182,012 6,320,318 29,057,203 CDEL CITADEL SECURITIES LLC 2,254,605 1 43.51%
CTIX Cellceutix Corp 5,182,012 6,320,318 29,057,203 NITE KCG AMERICAS LLC 736,389 2 14.21%
CTIX Cellceutix Corp 5,182,012 6,320,318 29,057,203 ETRF G1 EXECUTION SVCs, LLC 620,365 3 11.97%



none of this data is difficult to digest .. but it is time consuming which imo is exactly what NR counts on with *retail*

http://otce.finra.org/MonthlyShareVolume

note tho' the *lowest* % was a year ago May b4 mgmt's UPSIDE surprise of June 2017 .. note the following months' %s .. and then compare against PPS *relentless* compression in alignment with a *reduced* volume avg .. (i.e. NRs' Struggle to pry IPIX shares)

folks should also remember that the *legal* data reported in May 2017 vs July 2017 ..

Settlement Date
Issue Name
Symbol
Market
Current Short
Previous Short
Chg
% Change from Prev
Avg Daily Vol
Days to Cover


 
05/15/2017 Cellceutix Corp CTIX 1,037,384 875,733 161,651 18.46 354,459 2.93
05/31/2017 Cellceutix Corp CTIX 1,161,877 1,037,384 124,493 12 579,670 2

 
06/15/2017 Innovation Pharma IPIX 1,234,237 1,161,877 72,360 6.23 650,213 1.9
06/30/2017 Innovation Pharma IPIX 1,458,432 1,234,237 224,195 18.16 594,048 2.46
07/14/2017 Innovation Pharma IPIX 1,302,241 1,458,432 -156,191 -10.71 609,859 2.14
07/31/2017 Innovation Pharma IPIX 1,206,257 1,302,241 -95,984 -7.37 389,777 3.09


now note what the most recent (next set of dated data due out ah's on 5.24.18)
*legal* reported .. and take note of the avg daily volume *reported* re: IPIX .. from 2017 to this past month .. note .. it bears zero resemblance to being factual perhaps it's a *tell* or NR is projecting *intent* re: IPIX *volume* ..

 
04/30/2018 Innovation Pharma IPIX 1,113,653 1,131,509 -17,856 -1.58 536,933 2.07


http://otce.finra.org/ESI

4kids

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 13

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 18

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 9

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 10

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 17

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Updated Category News Views 13

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 13

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations

Updated Category News Views 12

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 15

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 10

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Legal Data: The Breakthrough of Robin AI

Updated Category News Views 306

Transforming Legal Data Management with AI In today's digital landscape, managing legal data effectively is crucial for businesses looking to thrive. Robin AI introduces a groundbreaking generative AI tool designed to turn contracts into structured data, streamlining legal operations and enhancing overall productivity. Unlocking the Value of Contracts By leveraging Robin...

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 18

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading
Exacto Receives Growth Investment from S2G Ventures and Skyline

Updated Category News Views 290

Exacto Announces Strategic Growth Investment This partnership is set to boost Exacto's innovation capabilities, broaden its geographic reach, and promote sustainable growth within the agriculture sector. Exacto®, LLC, a key player in agricultural innovation, has recently secured a substantial growth investment from S2G Ventures and Skyline Global Partners. This funding...

Continue Reading
Barclays Strengthens Technology Investment Banking Team with Singhal

Updated Category News Views 548

Barclays Expands Its Technology Investment Banking Division Barclays has made an important announcement regarding its Technology Investment Banking division by appointing Abhishek Singhal as a Managing Director. Singhal will concentrate on the Payments sector, which plays a crucial role in this fast-evolving financial landscape. He will be based in New York and will...

Continue Reading
Universal Technical Institute to Host Year-End Financial Call

Updated Category News Views 178

Universal Technical Institute's Upcoming Conference Call Universal Technical Institute, Inc. (NYSE: UTI), a prominent player in workforce education programs, is set to host a conference call to discuss critical financial and operational results for its fiscal fourth quarter and full year. The call is scheduled for Wednesday at 4:30 p.m. Eastern time. Stakeholders can look...

Continue Reading